MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Serological analysis of circulating Alpha Synuclein protein levels by Surface Plasmon Resonance (SPR) In Parkinson’s disease

A. Singh, T. Bajaj, A. Dey, S. Dey (New Delhi, India)

Meeting: 2019 International Congress

Abstract Number: 1085

Keywords: Alpha-synuclein, Parkinsonism

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: α-synuclein (α-Syn) is a presynaptic protein whose overexpression or misfolding contributes to the pathophysiology of Parkinson’s disease (PD). This study aims to estimate the α-Syn levels concentration in serum by real time, label free Surface Plasmon Resonance (SPR) technique which is well established technique for biomarker discovery in pico molar range.

Background: In India 7 million people are affected with PD. The WHO estimated the prevalence of PD in India is 160 per 1000,000. Oligomeric α-syn is the pathologic hall mark of PD. α-Syn levels can be potential clinical protein marker for PD, but several studies have reported different results. Analysing the body fluids (e.g. blood, urine, saliva, tear etc.) proteome is the promising approach to identify protein marker for diseases. Circulatory proteins reflects human physiological or pathological condition. Blood based biomarker is noninvasive technique, more helpful for screening large population and helpful for elderly patients.

Method: The concentration of α-Syn in serum samples of 38 PD patients and 33 control group (CG) individuals were quantified by surface plasmon resonance (SPR). The study was approved by AIIMS, New Delhi Ethics Committee (IESC/iT-461/30.9.2015) and written consent was obtained from subjects. The receiver operating characteristic curves(ROC) was plotted to evaluate it as circulating blood based protein biomarker. The  sensitivity, specificity and area under curve (AUC) obtained from ROC curve analysis disclosed the accuracy to differentiate PD from GCl in respect to serum α-Syn levels.

Results: α-Syn level was significantly (p≤0.0001) higher in PD patients (38.20±4.22ng/µL) than CG (34.31±3.23 ng/µL). AUC for α-Syn were found to be  0.753. Cut-off value of ≥35.94 ng/µL for α-Syn resulted in sensitivity of 69.7% and a specificity of 68.6% for PD diagnosis. The correlation of serum  α-Synuclein with duration of disease, age, BMI andUPDRS-III was evaluated. The levels of α-Syn increases with progressive UPDRS-III score.Furthermore, there was no signifcant correlation of α-Syn levels were detected with various d covariates  in PD. [table1]; [table2]; [figure1]; [figure2]

Conclusion: It can be summarized from our report that α-Syn can be one of the potential diagnostic protein markers for PD and differentiate it from elderly controls in Indian population by SPR.

figure1

figure 2

Table-1

Table-2 1

To cite this abstract in AMA style:

A. Singh, T. Bajaj, A. Dey, S. Dey. Serological analysis of circulating Alpha Synuclein protein levels by Surface Plasmon Resonance (SPR) In Parkinson’s disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/serological-analysis-of-circulating-alpha-synuclein-protein-levels-by-surface-plasmon-resonance-spr-in-parkinsons-disease/. Accessed May 17, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/serological-analysis-of-circulating-alpha-synuclein-protein-levels-by-surface-plasmon-resonance-spr-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley